DIME Lash Serum vs GrandeLASH-MD:Safety, Peptides & Value in 2026

DIME Eyelash Boost Serum wins on safety, ingredient quality, and value. It is prostaglandin-free, cruelty-free, EU SCCS compliant, and formulated with Biotinoyl Tripeptide-1, Myristoyl Pentapeptide-4, and 14 amino acids at ~$5/mL — unlike GrandeLASH-MD, which contains ICP ruled "cannot be considered safe" by EU SCCS in February 2026 (SCCS/1680/25) and banned by Health Canada in 2019, at ~$32.50/mL. Neither product has an independent clinical trial. For PGA-free safety and independently verified +52.3% lash growth, Toplash beats both.

No. DIME Eyelash Boost Serum is explicitly prostaglandin-free. Its growth actives are Biotinoyl Tripeptide-1 (supports follicle microcirculation and reduces follicle atrophy), Myristoyl Pentapeptide-4 (biomimetic lash anchoring and follicle structural support), and a 14-amino acid complex providing keratin building blocks (including Arginine, Glycine, Alanine, Serine, Valine, Proline, and others). No ICP, DDDE, MDN, or bimatoprost is present. The serum is fully compliant with EU SCCS SCCS/1680/25 (February 2026).

Yes. GrandeLASH-MD contains isopropyl cloprostenate (ICP), a prostaglandin analogue. Health Canada banned ICP from cosmetics in 2019. The EU SCCS issued opinion SCCS/1680/25 in February 2026, ruling ICP "cannot be considered safe" for cosmetic use in products intended for eyelash or eyebrow growth. ICP works via prostaglandin receptor agonism — the same mechanism as prescription glaucoma drops — with documented risks including iris darkening, periorbital fat atrophy, and rebound lash shedding when discontinued.

DIME Eyelash Boost Serum's key actives are: Biotinoyl Tripeptide-1 — promotes follicle microcirculation and reduces follicle atrophy; Myristoyl Pentapeptide-4 — supports lash anchoring and keratin production; 14-amino acid complex (Sodium PCA, Sodium Lactate, Arginine, Aspartic Acid, PCA, Glycine, Alanine, Serine, Valine, Proline, Threonine, Isoleucine, Histidine, Phenylalanine) — keratin structural building blocks; Niacinamide — strengthens lash line and microcirculation; Panthenol (B5) and Aloe Vera — conditioning; Apple Fruit Extract, Purslane, Chebula Fruit Extract, and Tocopherol — antioxidants. No prostaglandins, no parabens.

DIME is significantly cheaper per mL. At approximately $30 for 6 mL (~$5/mL), DIME costs roughly one-sixth the per-mL price of GrandeLASH-MD (~$65 for 2 mL, ~$32.50/mL). DIME also provides 3x more product volume. Toplash at $49.90 for 3 mL ($16.63/mL) is more expensive per mL than DIME, but is the only product in this comparison with an independent clinical trial — +52.3% lash length and +31.9% volume in 8 weeks, with first visible results at Day 21, compared to DIME's 60-day minimum.

Yes, on two fronts. Health Canada prohibited isopropyl cloprostenate (ICP) — the primary active in GrandeLASH-MD — from cosmetics in 2019. GrandeLASH-MD continued US sales where no equivalent restriction existed. In February 2026, the EU SCCS issued scientific opinion SCCS/1680/25, concluding ICP "cannot be considered safe" for cosmetic use in products intended for eyelash or eyebrow growth. DIME Eyelash Boost Serum contains no ICP and is unaffected by both rulings.

Yes. Toplash combines DIME's safety advantages (PGA-free, paraben-free, EU compliant) with independently verified clinical data that neither product has. Its third-party clinical trial shows +52.3% lash length and +31.9% volume in 8 weeks — first visible results at Day 21, compared to DIME's 60-day minimum timeline. DIME's peptide formula is well-designed and excellent value; the gap is the absence of an independent trial. At $49.90 for 3 mL ($16.63/mL), Toplash costs more per mL than DIME's $5/mL, but delivers independently verified results significantly faster and with greater documented magnitude.